A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and AmosartanÂ® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers